東京大学 · 医学
Shota Tanaka教授の研究室は、神経腫瘍学分野における画像診断と治療意思決定支援の高度化を目的としており、特にMRI画像のマシンラーニングを用いた腫瘍の分類・予後予測に注力しています。特に、好酸球性肉腫(chordoma)と軟骨肉腫(chondrosarcoma)の画像的特徴を機械学習で区別する画像情報学的アプローチが特徺です。また、神経腫瘍学分野の研究動向を予測するアルゴリズムの構築や、脳腫瘍患者に対する日本語版MDASI-BTの開発・検証など、臨床的応用に直結する研究を展開しています。
Figures are computed from collected data and may differ slightly.
Chordoma and chondrosarcoma share common radiographic characteristics yet are distinct clinically. A radiomic machine learning model differentiating these tumors preoperatively would help plan surgery. MR images were acquired from 57 consecutive patients with chordoma (N = 32) or chondrosarcoma (N = 25) treated at the University of Tokyo Hospital between September 2012 and February 2020. Preoperative T1-weighted images with gadolinium enhancement (GdT1) and T2-weighted images were analyzed. Data
In conducting medical research, a system which can objectively predict the future trends of the given research field is awaited. This study aims to establish a novel and versatile algorithm that predicts the latest trends in neuro-oncology. Seventy-nine neuro-oncological research fields were selected with computational sorting methods such as text-mining analyses. Thirty journals that represent the recent trends in neuro-oncology were also selected. As a novel concept, the annual impact (AI) of
Abstract Johan Hjort's “critical period” hypothesis, which postulates that year‐class strength is determined in the short period following the onset of exogenous feeding, has rarely been supported by empirical data. Instead, the current understanding is that recruitment is determined by cumulative mortality throughout early life. Recent studies relied on the measure of growth autocorrelation derived from otolith daily increment widths to test the link between growth rate achieved during the post
The newly developed MDASI-BT-Japanese has demonstrated feasibility, reliability and validity in evaluation of clinical benefit in Japanese-speaking brain tumor patients.
Open papers in the app to read, cite, and organize with AI.